2012
DOI: 10.1016/j.jacceco.2011.09.005
|View full text |Cite
|
Sign up to set email alerts
|

Measuring securities litigation risk

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

15
285
1

Year Published

2012
2012
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 683 publications
(322 citation statements)
references
References 58 publications
(43 reference statements)
15
285
1
Order By: Relevance
“…In addition, ex ante levels of litigation risk may affect a firm's disclosure choices in this setting. However, simple measures of ex ante litigation risk generally do a poor job of differentiating between actual levels of ex ante litigation risk (Kim and Skinner 2010). Thus, in this study I implicitly assume that ex ante litigation risk is constant across my sample, which may reduce the power of my tests.…”
Section: Test Three Hypotheses Related To My Predictions First I mentioning
confidence: 99%
“…In addition, ex ante levels of litigation risk may affect a firm's disclosure choices in this setting. However, simple measures of ex ante litigation risk generally do a poor job of differentiating between actual levels of ex ante litigation risk (Kim and Skinner 2010). Thus, in this study I implicitly assume that ex ante litigation risk is constant across my sample, which may reduce the power of my tests.…”
Section: Test Three Hypotheses Related To My Predictions First I mentioning
confidence: 99%
“…To benchmark the litigation rate of foreign firms we create a propensity score based matched sample of U.S. firms that have similar risk of getting sued as the foreign sample based on the litigation risk model in Kim and Skinner (2012). The litigation rate for foreign firms is 2.16%…”
mentioning
confidence: 99%
“…Research on predicting litigation risk focuses on U.S. companies (e.g., DuCharme et al, 2004;Field, Lowry, and Shu, 2005;Kim and Skinner, 2012) and does not examine foreign companies listed in U.S.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Panel B of Table 10 shows the difference-in-difference of the variables for the 44 "treated" 25 In untabulated tests, I have included more additional specific controls for each specification, including prior probability of beating guidance, proportion of guiding firms within the industry, frequency of capital raising activities, research and development expenses (Brown and Kimbrough 2011), return synchronicity (Morck et al 2000), return skewness (as an additional variable for predicting litigation risk in Kim and Skinner 2012), etc. Similar results are obtained.…”
Section: Additional Controlsmentioning
confidence: 99%